{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:32:18Z","timestamp":1759541538712,"version":"3.43.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,13]]},"DOI":"10.7759\/cureus.90018","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T21:41:42Z","timestamp":1755121302000},"source":"Crossref","is-referenced-by-count":1,"title":["Atrioventricular Block Caused by Carteolol Eye Drops Administered to Unilateral Eye or Bilateral Eyes: A Case Report"],"prefix":"10.7759","author":[{"given":"Keiji","family":"Yoshioka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960190104","article-title":"Cardiovascular effects of commonly used ophthalmic medications","volume":"19","author":"Shiuey Y","year":"1996","unstructured":"Shiuey Y, Eisenberg MJ. Cardiovascular effects of commonly used ophthalmic medications. Clin Cardiol. 1996, 19:5-8. 10.1002\/clc.4960190104","journal-title":"Clin Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199711050-00003","article-title":"Systemic adverse effects of topical ophthalmic agents: implications for older patients","volume":"11","author":"Diamond JP","year":"1997","unstructured":"Diamond JP. Systemic adverse effects of topical ophthalmic agents: implications for older patients. Drugs Aging. 1997, 11:352-60. 10.2165\/00002512-199711050-00003","journal-title":"Drugs Aging"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110948","article-title":"Strong independent association between third-degree AV-block and diabetes mellitus using a large database","volume":"205","author":"Movahed MR","year":"2023","unstructured":"Movahed MR, Bahrami A, Manrique C, Hashemzadeh M. Strong independent association between third-degree AV-block and diabetes mellitus using a large database. Diabetes Res Clin Pract. 2023, 205:110948. 10.1016\/j.diabres.2023.110948","journal-title":"Diabetes Res Clin Pract"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2024.10.007","article-title":"The association between chronic kidney\u00a0disease and third-degree atrioventricular block: a Danish nationwide study","volume":"11","author":"Wood-Kurland HK","year":"2025","unstructured":"Wood-Kurland HK, N\u00f8rskov AS, Carlson N, et al.. The association between chronic kidney\u00a0disease and third-degree atrioventricular block: a Danish nationwide study. JACC Clin Electrophysiol. 2025, 11:376-85. 10.1016\/j.jacep.2024.10.007","journal-title":"JACC Clin Electrophysiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.5598-20","article-title":"Bradycardia shock caused by the combined use of carteolol eye drops and verapamil in an elderly patient with atrial fibrillation and chronic kidney disease","volume":"60","author":"Arai R","year":"2021","unstructured":"Arai R, Fukamachi D, Monden M, et al.. Bradycardia shock caused by the combined use of carteolol eye drops and verapamil in an elderly patient with atrial fibrillation and chronic kidney disease. Intern Med. 2021, 60:79-83. 10.2169\/internalmedicine.5598-20","journal-title":"Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5830\/CVJA-2015-030","article-title":"Management and outcome of topical beta-blocker-induced atrioventricular block","volume":"26","author":"\u00d6zcan KS","year":"2015","unstructured":"\u00d6zcan KS, G\u00fcng\u00f6r B, Osmonov D, et al.. Management and outcome of topical beta-blocker-induced atrioventricular block. Cardiovasc J Afr. 2015, 26:210-3. 10.5830\/CVJA-2015-030","journal-title":"Cardiovasc J Afr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-5273(01)00489-2","article-title":"Third degree AV block due to ophthalmic timolol solution","volume":"80","author":"Sharifi M","year":"2001","unstructured":"Sharifi M, Koch JM, Steele RJ, et al.. Third degree AV block due to ophthalmic timolol solution. Int J Cardiol. 2001, 80:257-9. 10.1016\/s0167-5273(01)00489-2","journal-title":"Int J Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-019-0370-2","article-title":"Complete atrioventricular block due to timolol eye drops: a case report and literature review","volume":"20","author":"Wang Z","year":"2019","unstructured":"Wang Z, Denys I, Chen F, et al.. Complete atrioventricular block due to timolol eye drops: a case report and literature review. BMC Pharmacol Toxicol. 2019, 20:73. 10.1186\/s40360-019-0370-2","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.95.115","article-title":"Characterization of intrinsic sympathomimetic activity of carteolol in rat cardiovascular preparations","volume":"95","author":"Floreani M","year":"2004","unstructured":"Floreani M, Froldi G, Cavalli M, et al.. Characterization of intrinsic sympathomimetic activity of carteolol in rat cardiovascular preparations. J Pharmacol Sci. 2004, 95:115-23. 10.1254\/jphs.95.115","journal-title":"J Pharmacol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/03602530902722679","article-title":"Pharmacokinetics and drug metabolism in the elderly","volume":"41","author":"Klotz U","year":"2009","unstructured":"Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009, 41:67-76. 10.1080\/03602530902722679","journal-title":"Drug Metab Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02762-0","article-title":"The effect of \u03b2-blocker eye drops on pulse rate, ocular blood flow, and glaucoma progression: a retrospective longitudinal study","volume":"41","author":"Kiyota N","year":"2024","unstructured":"Kiyota N, Shiga Y, Ninomiya T, et al.. The effect of \u03b2-blocker eye drops on pulse rate, ocular blood flow, and glaucoma progression: a retrospective longitudinal study. Adv Ther. 2024, 41:730-43. 10.1007\/s12325-023-02762-0","journal-title":"Adv Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/15569527.2024.2402408","article-title":"A national analysis of systemic adverse events of beta-blockers used for glaucoma therapy","volume":"43","author":"Aftab OM","year":"2024","unstructured":"Aftab OM, Khan H, Sangani R, Khouri AS. A national analysis of systemic adverse events of beta-blockers used for glaucoma therapy. Cutan Ocul Toxicol. 2024, 43:293-8. 10.1080\/15569527.2024.2402408","journal-title":"Cutan Ocul Toxicol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.0495-22","article-title":"Life-threating vasospastic angina induced by carteolol eye drops","volume":"62","author":"Eto R","year":"2023","unstructured":"Eto R, Kawano H, Suzuki A, et al.. Life-threating vasospastic angina induced by carteolol eye drops. Intern Med. 2023, 62:2513-6. 10.2169\/internalmedicine.0495-22","journal-title":"Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.6150-20","article-title":"Exercise-induced atrioventricular block","volume":"60","author":"Aizawa Y","year":"2021","unstructured":"Aizawa Y, Kawamura A. Exercise-induced atrioventricular block. Intern Med. 2021, 60:827-8. 10.2169\/internalmedicine.6150-20","journal-title":"Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.9398-17","article-title":"Exercise-induced atrioventricular block with coronary artery stenosis that appeared five years after bypass surgery","volume":"57","author":"Yamazaki S","year":"2018","unstructured":"Yamazaki S, Kato T, Ushimaru S, Yokoi H, Mani H. Exercise-induced atrioventricular block with coronary artery stenosis that appeared five years after bypass surgery. Intern Med. 2018, 57:363-6. 10.2169\/internalmedicine.9398-17","journal-title":"Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac662","article-title":"Type 2 diabetes mellitus and higher rate of complete atrioventricular block: a Danish nationwide registry","volume":"44","author":"Haxha S","year":"2023","unstructured":"Haxha S, Halili A, Malmborg M, et al.. Type 2 diabetes mellitus and higher rate of complete atrioventricular block: a Danish nationwide registry. Eur Heart J. 2023, 44:752-61. 10.1093\/eurheartj\/ehac662","journal-title":"Eur Heart J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v12.i6.855","article-title":"Cardiovascular autonomic neuropathy in diabetes: pathophysiology, clinical assessment and implications","volume":"12","author":"Duque A","year":"2021","unstructured":"Duque A, Mediano MF, De Lorenzo A, Rodrigues LF Jr. Cardiovascular autonomic neuropathy in diabetes: pathophysiology, clinical assessment and implications. World J Diabetes. 2021, 12:855-67. 10.4239\/wjd.v12.i6.855","journal-title":"World J Diabetes"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/400120-atrioventricular-block-caused-by-carteolol-eye-drops-administered-to-unilateral-eye-or-bilateral-eyes-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T21:41:43Z","timestamp":1755121303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/400120-atrioventricular-block-caused-by-carteolol-eye-drops-administered-to-unilateral-eye-or-bilateral-eyes-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.90018","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,13]]}}}